US SB1227 | 2019-2020 | 116th Congress

Status

Spectrum: Slight Partisan Bill (Republican 6-3)
Status: Introduced on April 29 2019 - 25% progression, died in chamber
Action: 2019-06-28 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 131.
Text: Latest bill text (Introduced) [PDF]

Summary

Requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescriptions drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription Pricing for the People Act of 2019

Sponsors


History

DateChamberAction
2019-06-28SenatePlaced on Senate Legislative Calendar under General Orders. Calendar No. 131.
2019-06-28SenateCommittee on the Judiciary. Reported by Senator Graham with an amendment in the nature of a substitute. Without written report.
2019-06-27SenateCommittee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
2019-04-29SenateRead twice and referred to the Committee on the Judiciary.

Same As/Similar To

SB1227 (Related) 2019-06-28 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 131.
HB2376 (Related) 2019-05-21 - Subcommittee Hearings Held.
HB2296 (Related) 2019-09-24 - Placed on the Union Calendar, Calendar No. 170.
HB19 (Related) 2019-12-19 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.

Subjects


US Congress State Sources


Bill Comments

feedback